US government tells vaccine makers to price updated COVID shots reasonably

US government tells vaccine makers to price updated COVID shots reasonably COVID vaccine makers should price their updated shots for the fall at a reasonable rate that would reflect the benefits they received through government investments, the U.S. Department of Health and Human Services (HHS) said on Thursday. Reuters Reuters

...

The U.S. government will also launch a $1 billion "Bridge Access Program" for this fall, to help those without insurance and the underinsured to continue getting vaccines and treatments at no cost.

The appeal from the HHS to the vaccine makers – Pfizer (PFE.N)/BioNTech (22UAy.DE), Moderna (MRNA.O) and Novavax (NVAX.O) – comes at a time when the United States is moving to a commercial marketplace for COVID products from government purchases in the early years of the pandemic. ...

ALSO SEE: Senate Democrats press government to extend free Covid-19 tests indefinitely